Berkeley SkyDeck

Drill Surgeries is a technology company specializing in AI-powered surgical navigation systems for trauma and orthopedic procedures. Their proprietary AI algorithms and mixed reality technologies aim to significantly reduce operating room time and enhance surgical precision, thereby minimizing failure rates and unnecessary radiation exposure. By doing so, they help hospitals save substantial costs per operation.

We are an innovative AI-driven digital pathology company, dedicated to shaping the future of diagnostics and research, with a mission to empower accurate diagnoses and elevate patient care globally.

Okomera is a biotech start-up focused on enhancing the development of precision-based cancer medicines. The company specializes in automating and streamlining individualized tumor biopsy research through innovative medical technologies. By utilizing microfluidic 3D cellular assays, Okomera's approach allows for the prediction of patient-specific responses to therapies. This is achieved by cultivating cells within thousands of microfluidic droplets and exposing them to various conditions in parallel, which accelerates the process of biologically relevant biopsy testing. Consequently, Okomera's technologies enable healthcare providers to expedite cancer treatment, ultimately improving patient outcomes.

AsparaGlue is a medical technology company specializing in the development of a superglue-like adhesive for external wound closure and internal tissue adhesion. Their product is designed to be biocompatible and biodegradable, promoting faster surgical recovery and improved patient outcomes.

AsparaGlue is a medical technology company specializing in the development of a superglue-like adhesive for external wound closure and internal tissue adhesion. Their product is designed to be biocompatible and biodegradable, promoting faster surgical recovery and improved patient outcomes.

Gisens Biotech is a biotechnology firm specializing in bioelectronics and nanotechnology. The company is recognized for its innovative approach to problem-solving and employs advanced technology to enhance its offerings. One of its flagship products is the Nano-Lab, a portable diagnostic device designed to measure and control various biomarkers. This device can accurately analyze concentrations of renal biomarkers such as urea, creatinine, and potassium from a single drop of blood, urine, or saliva. By providing real-time measurements through a user-friendly application, the Nano-Lab enables efficient health monitoring, potentially transforming the way biomarker assessments are conducted and interpreted.

Music Health is a company dedicated to enhancing the well-being of individuals through the therapeutic use of music. Focused on making music therapy accessible and affordable, it aims to empower people to manage their mental health effectively. The company's flagship product, Vera, is designed to assist the 60 million individuals living with dementia and their nearly 200 million caregivers by addressing behavioral and psychological symptoms associated with the condition. Additionally, Music Health has developed a music application that generates mood-based playlists, allowing users to create tailored musical experiences that can adapt to various settings, such as social gatherings, commutes, or work environments. By combining technology with the healing power of music, Music Health seeks to improve the quality of life for its users.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support in disease management. Its mission is to establish a global reference platform that aids clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By leveraging advanced technology, GenomeUp aims to accelerate diagnosis times, enhance patient care, and contribute to health prevention efforts, all within a 24-hour timeframe. Committed to social responsibility, the founders have transformed GenomeUp into an Italian Benefit Corporation, emphasizing sustainability, transparency, and a focus on the well-being of stakeholders, communities, and the environment.

CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.

DeepScribe Inc, established in 2017 and headquartered in Berkeley, California, offers an AI-powered medical scribe platform that automates the process of medical documentation for healthcare providers. The technology uses artificial intelligence, machine learning, and natural language processing to capture and transcribe clinical conversations in real time, extracting pertinent medical information and organizing it into cohesive medical notes. This fully automated solution alleviates the burden of documentation from clinicians, allowing them to concentrate on patient care. DeepScribe's user-friendly mobile application and its integrations with various electronic health record (EHR) vendors enhance the efficiency of capturing documentation, ultimately transforming the way healthcare providers deliver services.

Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Appa Health is a digital mental health management platform focused on addressing the mental health challenges faced by teenagers. The platform promotes accountability by ensuring that teens engage with video-based courses and apply the skills they learn. It connects users with relatable near-peer mentors, fostering a supportive environment for mental well-being. Additionally, Appa Health integrates technology, therapeutic methods backed by research, care navigation specialists, and therapists to provide personalized mental health care tailored to the needs of adolescents. By emphasizing connection and understanding, the platform aims to empower teens to take charge of their mental health.

ImmunoMind Inc. is a biotechnology company based in Berkeley, California, founded in 2017. It specializes in developing an AI-based platform that enhances drug development programs through single-cell immunogenomics technologies. The company's offerings include Immunarch AI, a platform for precision drug discovery, and Immunarch, an open-source R package for bioinformatics. ImmunoMind focuses on improving T-cell therapies by accurately identifying T-cell subpopulations and their immune profiles. Its Augmented Intelligence platform aids in translational and clinical research, enhancing the quality, safety, and efficacy of therapies with single-cell precision. By leveraging proprietary single-cell multi-omics technologies, ImmunoMind evaluates cell differentiation, estimates exhaustion rates of subpopulations, and identifies off-tumor targets, supporting the design of immunotherapies, vaccine development, and systems immunology research.

Aila Health is a virtual precision health clinic focused on serving the approximately 50 million Americans affected by autoimmune diseases, predominantly women. Founded in 2020 and based in San Francisco, the company utilizes a data-driven platform that integrates patient information to facilitate personalized, multi-specialty care through a network of integrative care teams. Aila Health's clinical platform offers access to specialists, health coaches, personalized nutrition, and patient education, as well as remote monitoring devices. This comprehensive approach aims to enhance health outcomes while minimizing costs by enabling healthcare providers to deliver tailored care management based on each patient's unique health history, genetic profile, lifestyle, and environment.

Aesop Technology is a developer of artificial intelligence solutions focused on reducing prescription-related errors and enhancing patient safety. Founded in 2019 and based in Berkeley, California, the company offers MedGuard, an AI-enhanced safety system that supports various aspects of prescription management, including prescribing, dispensing, administering, and compliance services. Aesop Technology also provides a clinical decision support system that assists healthcare providers by flagging inappropriate prescriptions based on patient diagnosis, age, and gender. By leveraging machine learning, the company's technology aims to improve healthcare quality and safety while streamlining billing-related documentation, ultimately enhancing patient safety and the accuracy of medical billing.

Root Applied Sciences Inc. specializes in automated in-field DNA-based sensors designed to monitor airborne pathogens, providing crucial alerts to farmers via mobile notifications or automatic dashboard uploads. Founded in 2018 by Sarah Placella and headquartered in Oakland, California, the company offers subscription-based services that enable growers to apply pesticides more effectively by identifying the optimal timing for treatment. By collecting and analyzing airborne particles for DNA, Root Applied Sciences assists farmers in managing pathogens sustainably, helping them to reduce costs and minimize environmental impact while proactively addressing potential crop diseases.

Clinic Price Check is a company based in Santa Clara, California, that specializes in providing consumers with hospital price comparisons to facilitate informed healthcare decisions. Founded in 2019 by Joanne Rodrigues, the company offers cash prices for over 9,000 services at more than 350 hospitals across California. Utilizing public data from hospitals and government sources, including the Centers for Medicare and Medicaid Services, Clinic Price Check aims to enhance price transparency and promote competition within the healthcare sector. By empowering consumers with the necessary tools to compare prices, the platform helps individuals choose more affordable health providers and ultimately save money on medical services.

DeepRed Technologies, founded in 2019 by Chase Chen, Sanjay Rao, Junqiao Wu, and Kechao Tang, focuses on developing advanced applications in healthcare, energy, manufacturing, and artificial intelligence. The company specializes in thermal imaging technology that enhances the sensitivity of thermal cameras through the use of phase transition materials with engineered microstructures. This innovation significantly improves temperature resolution, allowing for various applications, including breast cancer screening, musculoskeletal imaging, and equipment inspection. DeepRed Technologies aims to provide safer and more accurate diagnostic methods while addressing critical needs across multiple sectors.

Acunon develops medical diagnostic devices that offer vitro tests for STD patients. The company makes it convenient and accessible for low-income consumers, women, the LGBTQ+ community, and the elderly. Acunon Health is headquartered in Berkeley, California.

DiffZero is a platform designed to enhance rehabilitation and training experiences for various users, including coaches, athletes, and patients undergoing recovery. The company focuses on providing support for ACL rehabilitation, aiming to improve outcomes for both patients and clinicians. By offering a personalized and interactive rehabilitation experience, DiffZero utilizes evidence-backed methods and advanced vision technology to deliver insights into movement tests. This approach enables clinicians to provide superior care, while helping patients effectively achieve their fitness goals.

MFluidX, Inc. is a diagnostic company based in Berkeley, California, that specializes in developing innovative microfluidic chips for the rapid detection of infectious diseases. Incorporated in 2015, the company has designed a portable DNA diagnostic test that is compact, roughly the size of a stick of gum, and capable of delivering results in just thirty minutes. This self-powered, disposable chip offers a cost-effective alternative to traditional bulky lab diagnostics, costing significantly less while maintaining high sensitivity through nucleic acid amplification. MFluidX focuses on addressing the urgent need for quickly deployable diagnostics in response to outbreaks of diseases such as Zika and Dengue, thereby enhancing the ability of healthcare providers to diagnose and manage infectious disease threats effectively.

Vision Science Labs, Inc. is a software company based in Palo Alto, California, that specializes in developing a digital platform for vision therapy and eye care. Founded in 2017, the company's solutions include comprehensive management tools for clinicians, exercise games for patients, and capabilities for remote training and assessment. This platform allows healthcare professionals to assign, monitor, and calibrate a complete training toolkit while conducting vision therapy online. In addition to its core focus on vision care, Vision Science Labs plans to expand its digital offerings into neurology, physical therapy, and general medicine, thus enhancing patient access to healthcare services and enabling early detection and treatment of visual conditions associated with significant diseases.

Dieta, Inc. is a San Francisco-based company founded in 2018 that develops an application focused on managing digestive health, particularly for individuals suffering from Irritable Bowel Syndrome (IBS). The app allows users to input detailed information about their food intake, physical activity, medications, and digestive health metrics. By utilizing machine learning algorithms and data science techniques, Dieta's platform analyzes this data to provide personalized insights and recommendations aimed at preventing digestive issues and alleviating symptoms associated with IBS. This innovative approach assists users in improving their overall quality of life by offering tailored guidance based on their unique health profiles.

CredibleMind, Inc. is an online platform that focuses on mental health, emotional well-being, and spiritual growth. The platform offers a range of content addressing issues such as anxiety, depression, stress, sleep, and meditation, along with a mobile application for easy access. CredibleMind aims to assist individuals in optimizing their mental health by providing curated, high-quality resources informed by academic and scientific insights. With a significant portion of U.S. adults facing mental or emotional health challenges yet lacking access to professional services, CredibleMind seeks to fill this gap by offering evidence-based self-care approaches. The company serves various sectors, including employers, insurers, healthcare providers, health departments, and community organizations. Founded in 2018 and based in Sausalito, California, CredibleMind was previously known as LifeView Inc. before rebranding in July 2019.

GenomEdge is a biotechnology company based in Berkeley, California, specializing in DNA testing services. Founded in 2019, the company focuses on providing advanced genetic analysis to individuals and organizations. Through its innovative testing solutions, GenomEdge aims to enhance understanding of genetic information, facilitating informed health and lifestyle decisions.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support in disease management. Its mission is to establish a global reference platform that aids clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By leveraging advanced technology, GenomeUp aims to accelerate diagnosis times, enhance patient care, and contribute to health prevention efforts, all within a 24-hour timeframe. Committed to social responsibility, the founders have transformed GenomeUp into an Italian Benefit Corporation, emphasizing sustainability, transparency, and a focus on the well-being of stakeholders, communities, and the environment.

Taiwan User-Friendly Sensor & Tech focuses on addressing food safety concerns, particularly regarding food allergens. The company develops Internet of Things (IoT) systems that facilitate on-site allergen detection. Its product lineup includes a multi-channel commercial detection module designed for use in food processing industries, restaurants, and hypermarkets, as well as a portable device intended for personal use. These devices are engineered to provide highly sensitive and accurate information about allergens in food within two minutes, enabling users to make informed decisions about what they consume. Based in China, Taiwan User-Friendly Sensor & Tech aims to enhance food safety through innovative technology.

Serinus Labs, Inc. is a manufacturer of nano-scale silicon gas sensors, established in 2017 and located in Berkeley, California. The company specializes in developing integrated chip-scale gas sensors tailored for various industries, including health and safety, automotive, consumer electronics, and healthcare. Serinus Labs offers custom solutions for both established and emerging gas sensor markets, focusing on applications such as Li-ion battery state-of-health monitoring. Their ultra-low-power trace gas sensors contribute to enhancing battery intelligence, particularly in electric vehicles, addressing critical needs in strategic markets.

Medostic, Inc. is a digital therapeutics company based in San Francisco, California, founded in 2017 by Michael Horning and George Brooks. The company specializes in developing proprietary integrated inpatient clinical decision support software aimed at personalizing metabolic treatment for critical care patients. Medostic's innovative software improves glycemic control and addresses other health indicators by utilizing measurements of glucose, lactate, and additional metabolites related to the body's energy state. By employing proprietary algorithms, the software enables healthcare professionals to prescribe personalized infusion administration of therapeutic formulations. This approach allows for a more nuanced understanding of the metabolic and nutritional needs of patients, ultimately enhancing their treatment outcomes in critical care settings.

DeepScribe Inc, established in 2017 and headquartered in Berkeley, California, offers an AI-powered medical scribe platform that automates the process of medical documentation for healthcare providers. The technology uses artificial intelligence, machine learning, and natural language processing to capture and transcribe clinical conversations in real time, extracting pertinent medical information and organizing it into cohesive medical notes. This fully automated solution alleviates the burden of documentation from clinicians, allowing them to concentrate on patient care. DeepScribe's user-friendly mobile application and its integrations with various electronic health record (EHR) vendors enhance the efficiency of capturing documentation, ultimately transforming the way healthcare providers deliver services.

Pinpoint Science, Inc. is engaged in the manufacture of bio-electronic diagnostics aimed at the detection, diagnosis, and surveillance of infectious diseases globally. Founded in 2015 and headquartered in San Francisco, California, the company specializes in a diagnostic device that leverages advanced biosensor technology. This device utilizes swappable cartridges to identify specific pathogens, including viruses, bacteria, and fungi, in various biofluids such as blood and saliva. By employing a unique approach based on functionalized nanopipettes, Pinpoint Science enables label-free electrical detection of biomolecules, offering improved accuracy and cost-effectiveness for the healthcare sector.

Fiat Lux Laboratories is a Biotechnology that develops a Biochemical Processing Sensor. The company was founded in 2017 by Yash Shah and is based in Berkeley, California.

Blumio, Inc. is a San Francisco-based company founded in 2014 that specializes in developing non-invasive wearable sensors for cardiovascular diagnostics, particularly blood pressure monitoring. The company’s innovative technology employs radio frequency to detect and analyze arterial tissue movements, allowing for continuous blood pressure measurement without the need for traditional inflatable cuffs. Blumio aims to address the limitations of conventional blood pressure monitoring methods, which typically rely on measurements taken at rest with a sphygmomanometer. By providing a portable sensor that can be integrated with everyday devices, such as an iPhone case, Blumio enables users to accurately track their blood pressure throughout daily activities, enhancing the understanding of cardiovascular health.

DotLab is a women's healthcare technology company that focuses on improving the diagnosis of active endometriosis. Utilizing biomarkers and machine learning, the company has developed a non-invasive tool that addresses the complexities of endometriosis recognition. By employing a multi-analyte, algorithmic approach, DotLab enables women to receive early diagnoses of active endometriosis, facilitating timely treatment and better management of the condition. This innovation represents a significant advancement in the identification and treatment of endometriosis, aiming to enhance the overall healthcare experience for women affected by this disease.

Nosocom Solutions focuses primarily on the development of technology solutions to prevent and reduce Healthcare-Associated Infections (HAI). The company was established in 2012 founded by Naresh Sunkara.

Lioness is a company that has developed an adaptive vibrator aimed at empowering women to understand, discover, and take control of their bodies. The product features advanced biometric sensors and is paired with an application that helps users visualize bodily responses and engage with a supportive community for personalized sexual advice. Through this innovative approach, women can gain insights into their sexual health, including arousal patterns and optimal timing for intimacy. The company emphasizes a women-centric design, utilizing materials typically found in medical devices and ergonomics tailored to how women naturally hold vibrators. With a leadership team composed predominantly of women, Lioness seeks to change the conversation around female sexuality and provide valuable resources for women to explore their sexual well-being.

Kryptos Biotechnologies, Inc. is a biotechnology company based in Hayward, California, founded in 2017 by Jinyong Lee and Jun Ho Son. The company specializes in life science tools that provide insights into cellular status by revealing unbiased genomic characteristics. Its flagship technology, Photonic PCR, facilitates rapid molecular diagnostics by employing a point-of-care ultrafast process that uses photothermal heating with a light-emitting diode. This innovative approach allows clinicians and scientists to diagnose infectious diseases quickly and cost-effectively, enhancing decision-making in clinical settings.

Karuna Labs Inc. specializes in developing digital therapeutics programs aimed at managing chronic pain. The company employs a unique approach that combines physical and cognitive retraining to address the complexities of pain. Its platform leverages targeted sensorimotor incongruences to deliver an integrated suite of services, including physical therapy, pain psychology, cognitive neuroscience, and functional restoration. This innovative method allows clinics, individuals, and research institutions to utilize virtual embodiment training as a means to treat chronic pain effectively. Through its offerings, Karuna Labs seeks to enhance pain management and rehabilitation outcomes for those suffering from persistent pain conditions.

Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

InkSpace Imaging, Inc., founded in 2016 and based in Pleasanton, California, specializes in the development of magnetic resonance imaging (MRI) receive coils. The company focuses on creating ultra-lightweight, customizable MRI coils designed to enhance patient comfort and optimize imaging performance, particularly for pediatric patients. By contouring to the body, these coils not only improve image quality but also facilitate faster setup times, thereby reducing the need for anesthesia during examinations. InkSpace Imaging aims to increase the accessibility and efficiency of MRI procedures while prioritizing the comfort and safety of its youngest patients.

Vivoo is a wellness application that offers personalized nutrition and lifestyle advice by analyzing users' urine samples. Founded in 2017 and based in Palo Alto, California, the platform provides insights on various health parameters, including vitamin C, magnesium, calcium, salinity, oxidative stress, hydration, ketones, and protein, all derived from weekly at-home urine tests. The app translates this data into actionable recommendations prepared by registered dieticians, nutritionists, and doctors, empowering users to make informed health choices that seamlessly integrate into their daily lives. Through its user-friendly approach, Vivoo helps individuals monitor their health and enhance their well-being.

Darmiyan, Inc. is a company that specializes in the development of diagnostic software aimed at the early detection and monitoring of Alzheimer's disease and other neurodegenerative disorders. Based in San Francisco and founded in 2014, the company offers BrainSee, a Software as a Service platform that utilizes non-invasive brain MRI scans to produce detailed brain maps. This innovative tool quantifies neurodegeneration in individual brain voxels and generates a summary score reflecting brain health and the risk of cognitive decline. BrainSee operates using proprietary technology, referred to as The Virtual Microscope, which provides insights into brain cell distortion before clinical symptoms manifest. The algorithm has undergone successful third-party validation in the US and Canada, demonstrating its accuracy in predicting mild cognitive impairment. By leveraging advanced medical imaging and artificial intelligence, Darmiyan aims to enhance early diagnosis and intervention for patients with neurodegenerative diseases.

Genomelink is a platform that empowers individuals to explore their DNA data and enables businesses to utilize this information for marketing and research purposes. Founded by experienced professionals in consumer genomics, including members with backgrounds from leading companies such as M3, Inc. and a joint venture between Illumina and Sony, Genomelink has raised $4 million in seed funding from notable investors, including Berkeley SkyDeck and prominent Japanese venture capital firms. The company's application allows users to upload their raw DNA data files, providing insights into their identities and traits through a user-friendly interface and educational content. This approach fosters a deeper understanding of genetic information while promoting transparency and engagement with personal data.

SwiftMotion develops wearable sensors and analytics aimed at enhancing the health and safety of industrial workers. The company's ergonomic systems utilize full-body motion capture technology to conduct precise ergonomic risk assessments, capturing data on load and force to identify potential hazards. By delivering actionable insights, SwiftMotion helps clients in sectors such as warehousing, distribution, airport transit, automotive, and insurance to implement effective interventions that reduce injury rates. This approach not only promotes worker well-being but also addresses the financial burden of workers' compensation costs.

Angilytics specializes in the development of a cardiovascular wellness platform in the form of a wristband designed to assist in the management of heart diseases. This innovative device provides healthcare professionals with vital cardiovascular data, including blood pressure and heart rate, through a patented sensor fusion technology and machine learning algorithms. The wristband enables remote monitoring and treatment of conditions such as heart failure, atrial fibrillation, and myocardial infarction. By facilitating continuous health tracking, Angilytics aims to improve patient outcomes, reduce hospital readmissions, and lower overall healthcare costs.

iTreatMD, Inc. operates a workflow platform designed for the healthcare sector, focusing on enhancing clinician-patient interactions. Based in San Francisco, California, the company offers an iPad application that enables healthcare providers to efficiently enter patient data, generate personalized encounter notes, and create tailored treatment plans. This application addresses significant challenges in modern healthcare, such as the increasing demand for improved patient outcomes within limited visit times and the rising costs of care. By optimizing the encounter time between providers and patients, iTreatMD aims to enhance the quality of patient care. The platform supports better documentation practices, reduces costs associated with traditional dictation and transcription methods, and minimizes billing inconsistencies, thereby fostering improved efficiencies in healthcare delivery. As the industry evolves with advancements in mobile technology and connectivity, iTreatMD seeks to democratize medical knowledge, ensuring that effective treatment strategies are accessible to a broader range of patients.

Stroll, Inc. specializes in developing an integrated referral management application designed to enhance patient care by providing seamless access to healthcare services. The platform includes features such as automatic insurance verification, out-of-pocket cost estimates, clinical decision support, prior authorization, real-time scheduling, and patient reminders. By leveraging tools like real-time eligibility checks, insurance co-pay estimates, and quality metrics, Stroll enables patients to identify suitable care options based on their individual needs. The comprehensive patient engagement system ensures effective communication before, during, and after medical appointments, facilitating better preparation and follow-up. Stroll's innovative cloud image sharing technology and physician-specific analytics further streamline the sharing of medical information, addressing common challenges in the healthcare space related to compatibility and transparency. Founded in 2013 and based in San Francisco, California, Stroll aims to simplify the healthcare experience for both patients and providers.

Outcomes.com focuses on enhancing healthcare through technology by aligning incentives to promote data-driven care and improve patient outcomes. The company develops pharmacy management systems and clinical applications tailored for various healthcare settings, including assisted living and hospital pharmacies. Its platforms provide valuable insights and analytics, facilitate insurance claims processing, enable e-prescription connectivity, and streamline pharmacy workflow management. By offering these services, Outcomes.com aims to assist clients in optimizing operations, expanding their businesses, increasing patient engagement, and ultimately achieving better healthcare outcomes.

Lioness is a company that has developed an adaptive vibrator aimed at empowering women to understand, discover, and take control of their bodies. The product features advanced biometric sensors and is paired with an application that helps users visualize bodily responses and engage with a supportive community for personalized sexual advice. Through this innovative approach, women can gain insights into their sexual health, including arousal patterns and optimal timing for intimacy. The company emphasizes a women-centric design, utilizing materials typically found in medical devices and ergonomics tailored to how women naturally hold vibrators. With a leadership team composed predominantly of women, Lioness seeks to change the conversation around female sexuality and provide valuable resources for women to explore their sexual well-being.

Picoyune is a chemical sensing company that specializes in portable mercury analysis. Utilizing patented plasmonic film technology, Picoyune has developed a robust detector that simplifies the analysis process, allowing individuals to operate it without the need for extensive laboratory equipment. The company aims to address the significant issue of mercury contamination, a potent neurotoxin and global pollutant, by adapting its technology to analyze soil and sediment samples from contaminated sites. By employing gold nanoparticles with peak absorption capabilities, Picoyune provides high-performance solutions in a compact format, meeting the demands of clients in environmental monitoring and remediation.

Privail specializes in developing point-of-care diagnostics aimed at the early detection of infectious diseases, with a primary focus on HIV. The company is dedicated to creating simple and affordable testing solutions that empower patients to seek timely medical treatment, ultimately improving their quality of life. Privail's team is composed of a diverse group of scientists and engineers from the University of California, Berkeley, and the University of California, San Francisco, who are united in their mission to enhance healthcare access for underserved populations. By offering in-home tests, Privail addresses the needs of both developing and developed nations, facilitating easier disease tracking and detection.

Crohnology operates a patient-centered research platform that empowers individuals with chronic medical conditions to contribute to research specifically related to their health. The platform serves as a hub for patients, their families, and friends, facilitating connections among users for a social cause. Through this network, participants can collaborate, share health and treatment information, and track their health progress. By fostering a community-focused approach, Crohnology aims to enhance understanding and research surrounding chronic illnesses, enabling patients to play an active role in their own healthcare journeys.